Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06814080 · ClinicalTrials.gov registry record
Residual Gastric Content and GLP-1
A clinical trial of Pre-op Gastric Emptying, sponsored by University of Arkansas.
- Recruiting
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT06814080: Recruiting study of Pre-op Gastric Emptying, sponsored by University of Arkansas.
NCT06814080 is a study of Pre-op Gastric Emptying that is actively recruiting participants, run by University of Arkansas. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06814080, a study of Pre-op Gastric Emptying, is actively recruiting participants, sponsored by University of Arkansas.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Studies have shown that even following the fasting guideline, patients on GLP-1 still have residual gastric content which increases their risk of aspiration during anesthesia. We aim to investigate the prevalence of full stomachs following different fasting times.
Primary Outcome
Empty stomach when no content or clear liquids are visibly inferior to 1.5ml/kg. Full stomach includes the visualization of solids on gastric ultrasonography or a volume of clear liquids greater than 1.5ml/kg.
Conditions Studied
Study Locations (1)
Arkansas
- University of Arkansas for Medical Science - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2025-05-22 |
| Est. Completion | 2026-08 |
What NCT06814080 shows while recruiting
NCT06814080 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 45 participants, a relatively small participant target.
The record links to 1 condition, with Pre-op Gastric Emptying appearing as the primary indexed condition, and to 0 interventions.
NCT06814080 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT06814080 about?
NCT06814080 is a clinical study titled "Residual Gastric Content and GLP-1". Studies have shown that even following the fasting guideline, patients on GLP-1 still have residual gastric content which increases their risk of aspiration during anesthesia. We aim to investigate the prevalence of full stomachs following different fasting times.
What is the current status of trial NCT06814080?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2025-05-22. Estimated completion is 2026-08.
What conditions does trial NCT06814080 study?
This clinical trial studies the following conditions: Pre-op Gastric Emptying.
Who is sponsoring clinical trial NCT06814080?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06814080 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI